TMCnet News
Global Artificial Intelligence in Diabetes Management Market Value Share, Analysis and Segments 2018-2024The latest report on Artificial Intelligence in Diabetes Management Market by Infinium Global Research gives complete coverage of the artificial intelligence in diabetes management market by the device (insulin delivery devices, diagnostic devices, glucose monitoring devices) in terms of key trends, market size, forecast. In addition, the study covers deep dive into key product and applications trends in the regional markets of artificial intelligence in diabetes management such as North America, Europe, Asia-Pacific and Latin America over the short run and long run. According to the report, the global artificial intelligence in diabetes management market is projected to grow at a CAGR of 47.55% over the forecast period of 2018-2024. For More Details Get FREE Sample Pages of this Premium Global Report@ https://www.infiniumglobalresearch.com/reports/sample-request/3241 Market Insight Diabetes is a major pervasive chronic disorder that impacts a large number of the global population. It is a global epidemic and the most expensive disease. Insulin-dependent (type 1) diabetes is managed by monitoring the blood glucose level with finger prick blood tests performed many times throughout the day and insulin levels are adjusted based on these readings. This invasive method is painful, inconvenient, time-consuming, and not good enough for managing a dynamic and complex disease condition such as diabetes. Various non-invasive methods of blood glucose measurement and insulin delivery are still in the development stage. Glucose measurement devices are now capable of continuously monitoring blood glucose levels throughout the day. The data-intensive nature of diabetes care and management makes it an ideal fit for applying artificial intelligence and machine learning to improve outcomes and find better solutions. Different applications of artificial intelligence (AI) and cognitive computing offer promise in diabetes care. Artificial intelligence methods in combination with the latest technologies, such as medical devices, mobile computing, and sensor technologies, have great potential to provide better services to deal with chronic diseases. Artificial intelligence, in healthcare, uses algorithms and software to approximate human cognition in the analysis of complex medical data. Artificial intelligence is being used for a wide range of healthcare and research applications, including detection of disease, management of chronic conditions, delivery of health services, and drug discovery. There is a large number of the global population suffering from diabetes and the number is growing rapidly. This is the major factor driving the global artificial intelligence in diabetes management market. Additionally, high penetration of internet and well-developed internet infrastructure in developed countries, increasing government spending on healthcare and new programs undertaken by the governments regarding awareness about chronic diseases is anticipated to drive the global artificial intelligence in diabetes management market. Furthermore, the patient-centric approach of healthcare and increasing utilization of smart monitoring devices to track health record of the patient are some of the factors which are likely to propel the market. However, the cost of the devices is a major factor responsible for hampering the growth of global artificial intelligence in diabetes management market. Furthermore, government stringent regulation regarding healthcare, lack of awareness, patient’s privacy and security concerns, lack of curated datasets and less digital savvy patients are some of the other restraining factors that would affect the market negatively. The rising elderly population, increasing obesity, favorable demographics, urbanization, rising healthcare costs, and increasing digital affinity are some of the factors acting as opportunities for the global artificial intelligence in diabetes management market. North America, Europe, Asia-Pacific, and RoW are the geographical regions for the global artificial intelligence in diabetes management market. North American region is dominating in the global artificial intelligence diabetes management market which attributes to the better internet infrastructure, development of latest and advanced technologies and growing government spending on healthcare in this region. The Asia Pacific region is expected to grow with a higher rate. Increasing investment in healthcare infrastructure in the emerging economies like China, India and South Korea will contribute to the growth of the market in the Asia Pacific region. Additionally, huge patient pool suffering from diabetes in this region will add to the demand for artificial intelligence diabetes management. Segment Covered The report on global artificial intelligence in diabetes management market covers segments such as device. On the basis of device, the sub-markets include insulin delivery devices, diagnostic devices, and glucose monitoring devices. Ask Discount for the Latest Research Report @ https://www.infiniumglobalresearch.com/reports/request-discount/3241 Competitive Landscape The report provides profiles of the companies in the market such as Apple Inc., Google Inc, Vodafone Group Plc, Diabnext, IBM Corporation, Tidepool, and Glooko Inc. Browse Complete Global Report and Detailed TOC: https://www.infiniumglobalresearch.com/healthcare-medical-devices/global-artificial-intelligence-in-diabetes-management-market As a community-building service, TMCnet allows user submitted content which is not always proofed by TMCnet editors. If you feel this entry is of inferior quality or wish to report it for some reason, please forward the URL to "webedit [AT] tmcnet [DOT] com" with your comments. |